
Fresenius Kabi Breaks Ground on $250-Million Facility Expansion
Fresenius Kabi broke ground on a previously announced $250 million expansion of its Melrose Park, IL, manufacturing facility.
On Sep. 21, 2017, Fresenius Kabi, a German specialty and generic pharmaceuticals company and a subsidiary of Fresenius SE & Co. KGaA, broke ground on a $250-million expansion of its Melrose Park, IL manufacturing facility. The site,
This investment is part of a recent series of business endeavors by the company. In April 2017, the company
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.